Compound information
- Natural Products
- ZC3053515
- Molecular Formula
- C30H38N4O7S
- Molecular Weight
- 598.246120556 g/mol
- Structure
-
- IUPAC Name
- tert-butyl N-[(1R)-5-(benzyloxycarbonylamino)-1-[[5-(methylsulfamoyl)-1-naphthyl]carbamoyl]pentyl]carbamate
- InChI
- InChI=1S/C30H38N4O7S/c1-30(2,3)41-29(37)34-25(16-8-9-19-32-28(36)40-20-21-12-6-5-7-13-21)27(35)33-24-17-10-15-23-22(24)14-11-18-26(23)42(38,39)31-4/h5-7,10-15,17-18,25,31H,8-9,16,19-20H2,1-4H3,(H,32,36)(H,33,35)(H,34,37)/t25-/m1/s1
- InChI Key
- WKNSVOUGPPPOHI-RUZDIDTESA-N
- SMILES
- CNS(=O)(=O)c1cccc2c(NC(=O)[C@@H](CCCCNC(=O)OCc3ccccc3)NC(=O)OC(C)(C)C)cccc12
- Source
- ZINC000029748846
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 42 | Ring Count | 3 |
Heteroatom Count | 12 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 151.93 Å2 | LogP | 4.087 |
LogS | -6.109 | LogD | 3.809 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.188 | Pgp substrate | 0.205 |
HIA | 0.966 | F20 % | 0.969 |
F30 % | 0.001 | Caco-2 | -5.153 |
MDCK | -5.829 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.15 | PPB | 86.959 |
VD | 0.916 | Fu | 2.185 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.564 | CYP1A2 substrate | 0.61 |
CYP2A6 substrate | 0.372 | CYP2B6 substrate | 0.64 |
CYP2C19 inhibitor | 0.979 | CYP2C19 substrate | 0.812 |
CYP2C8 substrate | 0.786 | CYP2C9 inhibitor | 0.95 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.585 |
CYP2D6 substrate | 0.979 | CYP2E1 substrate | 0.467 |
CYP3A4 inhibitor | 0.991 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.453 | CL | 2.847 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.02 | Hepatotoxicity | 0.897 |
Mutagenicity | 0.02 | Rat Oral Acute Toxicity | 0.16 |
FDAMDD | 0.405 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.004 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.016 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.576 | IGC50 | 4.367 |
LC50FM | 4.249 | LC50DM | 5.17 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.142 | NR-AR-LBD | 0.243 |
NR-AhR | 0.567 | NR-Aromatase | 0.055 |
NR-ER | 0.597 | NR-ER-LBD | 0.39 |
NR-PPAR-gamma | 0.819 | SR-ARE | 0.783 |
SR-ATAD5 | 0.431 | SR-HSE | 0.055 |
SR-MMP | 0.815 | SR-p53 | 0.132 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.